ENVALITH
株式会社ステムセル研究所 logo

StemCell Institute Inc.

7096Growth MarketServices

株式会社ステムセル研究所 logo
StemCell Institute Inc.7096
Reference Indicators

Market Cap

75¥100M

P/E (Forecast)

70.8x

P/B

2.7x

Dividend Yield (Forecast)

0.00%

ROE

5.8%

EV/EBITDA

14.2x
Financial Summary
Unit: ¥M
Item
2022Mar 2022
2023Mar 2023
2024Mar 2024
2025Mar 2025
2026Mar 2026
Net Sales
1,7812,0912,4812,6792,811
Cost of Sales
6707559059871,099
Gross Profit
1,1111,3351,5751,6921,712
SG&A Expenses
8841,0381,1621,2731,509
Operating Income
226297413418202
Non-operating Income
1281322
Non-operating Expenses
15437
Ordinary Income
212300417428217
Extraordinary Income
241360
Extraordinary Losses
21000
Pre-tax Income
212278441565217
Income Taxes
788013017986
Net Income
133198310385155
EBITDA
323402534546359
Gross Margin
62.4%63.9%63.5%63.2%60.9%
Operating Margin
12.7%14.2%16.7%15.6%7.2%
ROA
2.6%3.4%4.8%5.1%1.9%
ROE
7.8%9.0%12.5%14.5%5.8%